MIC + B12
An overview of lipotropic ingredients and vitamin B12. A prescriber should review allergies, medical conditions, medicines, and supplements before treatment.
Medication library
Clear, practical information to support conversations with your prescriber and pharmacist.
Review each topic with a licensed healthcare professional who knows your history, diagnoses, allergies, and current medicines. Website information should never be used to start, stop, change, or share a prescription.
An overview of lipotropic ingredients and vitamin B12. A prescriber should review allergies, medical conditions, medicines, and supplements before treatment.
Information about FDA-approved Ozempic and its semaglutide labeling. Approved indications, dosing, warnings, and contraindications govern its use.
Information about FDA-approved Wegovy and its semaglutide labeling. Review the Medication Guide, warnings, and contraindications with a healthcare professional.
Information about FDA-approved Mounjaro and its tirzepatide labeling. A licensed prescriber should review its indication, dosing, warnings, and contraindications.
Information about FDA-approved Zepbound and its tirzepatide labeling. Treatment requires an individual assessment and review of the approved labeling.
Hormone therapy carries significant risks for some patients. A prescriber should assess symptoms, history, contraindications, monitoring, dose, and duration.
Information about prescribed glutathione preparations. Potential reactions, route-specific risks, and storage depend on the formulation.
Injection technique, dose, site reactions, storage, and individual health risks require pharmacy and prescriber guidance.
Nasal irritation, dosing, storage, and safe handling should be reviewed before use.
Topical preparations can cause sensitivity or irritation. Use only as directed and report persistent reactions.
Patch-site irritation and ingredient sensitivity are possible. Follow application and storage directions supplied with the prescription.
Different dosage forms may require refrigeration, room-temperature storage, light protection, or other handling. The dispensed label controls.
Review sexual, mood, reproductive, prostate-screening, and pregnancy-exposure warnings with a prescriber. FDA approval varies by dosage form and use.
PDE5 inhibitors must never be combined with nitrates. Cardiovascular history, blood pressure, other medicines, and emergency symptoms require careful review.
Evidence varies by proposed use. A prescriber should evaluate the indication, contraindications, interactions, monitoring, and injection technique.